Adding Ribociclib Improves PFS in Premenopausal Breast Cancer

Dave LevitanJun 1, 2018Ribociclib plus endocrine therapy resulted in improved progression-free survival in premenopausal women with HR-positive, HER2-negative advanced breast cancer.

Source: CancerNetwork - June 1, 2018 Category: Cancer & Oncology Authors: A Source Type: news